Abstract
Based upon clinical experience Virchow introduced the concept of irritation-induced carcinogenesis in 1862 (Virchow 1863). Since then a significant body of information has been accumulated providing evidence for an intimate relationship between wounding, wound healing, and tumor development. It includes medical case reports suggesting an influence of injury or chronic irritation on human carcinogenesis (Mueller and Thornbury 1973; Sanderson and Mackie 1979) and results from several experimental models indicating that wounding, although not of itself a carcinogenic stimulus (Hasegawa et al. 1987), can act as a tumor promoter in animals exposed to initiating chemical or viral carcinogens. Thus, sarcomas develop at the site of experimental wounds in chickens infected with Rous sarcoma virus (Dolberg et al. 1985) and in v-jun transgenic mice (Schuh et al. 1990). Moreover, epidermal tumors arise at sites of increased mechanical stress in v-ras transgenic mice (Bailleul et al. 1990; Leder et al. 1990). Upon initiation with chemical carcinogens wounding induces tumor development in mouse and rat liver (Fisher and Fisher 1959: Pound and McGuirre 1978), in rat intestine (Pozharizski 1975; Chester et al. 1989), in mouse oral mucosa (Konstantinides and Smulov 1982), in rabbit ear (McKenzie and Rous 1941), and in mouse skin (Hennings and Boutwell 1970; Clark-Lewis and Murray 1978; Argyris 1980). More recently, a variety of growth factors which are produced and released in a temporarily and locally restricted manner during the wound response have been found to be constitutively expressed in tumor cells and to support tumor growth via an autocrine activation pathway (for review see Sporn and Roberts 1986; Heldin and Westermark 1989).
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Akhurst RJ, Fee F, Balmain A (1988a) Localized production of TGF-ß mRNA in tumour promoter-stimulated mouse epidermis. Nature 331: 363–365
Akhurst RJ, Lehnert SS, Fee F, Balmain A (1988b) The role of transforming growth factor-ß in mouse development and carcinogenesis. Biochem Soc Trans 17: 595–597
Antoniades HN, Galanopoulos T, Neville-Golden J, Kiritsy CP, Lynch SE (1991) Injury induces in vivo expression of platelet-derived growth factor ( PDGF) and PDGF receptor mRNAs in skin epithelial cells and PDGF mRNA in connective tissue fibroblasts. Proc Natl Acad Sci USA 88: 565–569
Argyris TS (1980) Tumor Promotion by abrasion-induced hyperplasia in skin of mice. J Invest Dermatol 75: 360–362
Bailleul B, Surani MA, White S, Barton SC, Brown K, Blessing M, Jorcano J, Balmin A (1990) Skin hyperkeratosis and papilloma formation in transgenic mice expressing a ras oncogene from a suprabasal Keratin promoter. Cell 62: 697–708
Barker JNWN, Mitra RS, Griffiths CEM, Dixit VM, Nickoloff BJ (1991) Keratinocytes as initiators of inflammation. Lancet 337: 211–214
Barrandon Y, Green H (1987) Cell migration is essential for sustained growth of keratinocyte colonies: the roles of transforming growth factor a and epidermal growth factor. Cell 50: 1131–1137
Bascom CC, Sipes NJ, Coffey RJ, Moses HL (1989) Regulation of epithelial cell proliferation by transforming growth factors. J Cell Biochem 39: 25–32
Blitstein-Willinger E (1991) The role of growth factors in wound healing. Skin Pharmacol 4: 175–182
Bottaro DP, Rubin JS, Ron D, Finch PW, Florio C, Aaronson SA (1990) Characterization of the receptor for keratinocyte growth factor. Evidence for multiple fibroblast growth factor receptors. J Biol Chem 265: 12767–12770
Chester JF, Gaissert HA, Ross JS, Malt RA, Weitzman SA (1989) Colonic cancer induced by 1,2-dimethylhydrazine: promotion by experimental colitis. Br J Cancer 59: 704–705
Clark-Lewis J, Murray AW (1978) Tumor promotion and the induction of epidermal ornithine decarboxylase activity in mechanically stimulated mouse skin. Cancer Res 38: 494–497
Coffey RJ, Derynck R, Wilcox JN, Bringman TS, Goustin AS, Moses HL, Pittelkow MR (1987) Production and autoinduction of transforming growth factor-alpha in human keratinocytes. Nature 328: 817–820
Cunningham F (1990) Lipid mediators in inflammatory skin disorders. J Lipid Mediator 2: 61–74
Dolberg DS, Hollingworth R, Hertle M, Bissel MJ (1985) Wounding and its role in RSV-mediated carcinogenesis. Science 230: 676–678
Dvorak HF (1986) Tumors: wounds that do not heal. N Engl J Med 315: 1650–1659
Elder JT, Fisher GJ, Lindquist PB, Bennett GL, Pittelkow MR, Coffey RJ, Ellingsworth L, Derynck R, Voorhees JJ (1989) Overexpression of transforming growth factor alpha in psoriatic epidermis. Science 243: 811–814
Finzi A, Kilkenny A, Stricklan JE, Balaschak M, Bringman T, Derynck R, Aaronson S, Yuspa SH (1988) TGF-alpha stimulates growth of skin papillomas by autocrine and paracrine mechanisms but does not cause neoplastic progression. Mol Carcinog 1: 7–12
Finzi E, Harkins R, Horn T (1991) TGF-a is widely expressed in differentiated as well as hyperproliferative skin epithelium. J Invest Dermatol 96: 328–332
Fisher B, Fisher ER (1959) Experimental evidence in support of the dormant tumor cell. Science 130: 918–919
Folkman J (1985) Tumor angiogenesis. Adv Cancer Res 43: 175–203
Folkman J, Klagsbrun M (1987) Angiogenic factors. Science 235: 442–447
Fürstenberger G, Marks F (1983) Growth stimulation and tumor promotion in skin. J Invest Dermatol 81: 157s - 161s
Fürstenberger G, Berry DL, Sorg B, Marks F (1981) Skin tumor promotion is a two-stage process. Proc Natl Acad Sci USA 78: 7722–7726
Fürstenberger G, Rogers M, Schnapke R, Bauer G, Höfler P, Marks F (1989) Stimulatory role of transforming growth factors in multistage carcinogenesis: possible explanation for the tumor-inducing effect of wounding in initiated NMRI mouse skin. Int J Cancer 43: 915–921
Gillitzer R, Berger R, Mielke V, Müller C, Wolff K, Stingl G (1991) Upper keratinocytes of psoriatic skin lesions express high levels of NAP-1/IL-8 mRNA in situ. J Invest Dermatol 97: 73–79
Glick AB, Flanders KC, Danielpour D, Yuspa SH, Sporn MB (1989) Retinoic acid induces transforming growth factor-ß2 in cultured keratinocytes and in mouse epidermis. Cell Regul 1: 87–97
Glick AB, Sporn MB, Yuspa SH (1991) Altered regulation of TGF-(31 and TGF-a in primary keratinocytes and papillomas expressing v-Ha-ras. Mol Carcinog 4: 210–219
Gottlieb AB, Chang CK, Posnett DN, Fanelli B, Tam JP (1988) Detection of transforming growth factor alpha in normal, malignant, and hyperproliferative human keratinocytes. J Exp Med 167: 670–675
Grossman RM, Krueger J, Yourish D, Granelli-Piperno A, Murphy DP, May LT, Kupper TS, Sehgal PB, Gottlieb A (1989) Interleukin 6 is expressed in high levels in psoriatic skin and stimulates proliferation of cultured human keratinocytes. Proc Natl Acad Sci USA 86: 6367–6371
Goustin AS, Leof EB, Shipley GD, Moses HL (1986) Growth factors and cancer. Cancer Res 46: 1015–1029
Haddow A (1972) Molecular repair, wound healing and carcinogenesis: tumor production a possible overhealing? Adv Cancer Res 16: 181–234
Haddow S, Fowlis DJ, Parkinson K, Akhurst RJ, Balmain A (1991) Loss of growth control by TGF-ß occurs at a late stage of mouse skin carcinogenesis and is independent of ras gene activation. Oncogene 6: 1465–1470
Halaban R, Langdon R, Birchall N, Cuaono C, Baird A, Scott G, Moellmann G, McGuire J (1988) Basic fibroblast growth factor from human keratinocytes is a mitogen for melanocytes. J Cell Biol 107: 1611–1619
Hasegawa R, St John M, Tibbels TS, Cohen SM (1987) Evaluation of epidermal cell kinetics following freezing or wounding of mouse skin and their potential as initiators of carcinogenesis. J Invest Dermatol 88: 652–656
Hebda PA (1988) Stimulatory effects of transforming growth factor-beta and epidermal growth factor on epidermal cell outgrowth from porcine skin explant cultures. J Invest Dermatol 91: 440–445
Heldin CH, Westermark B (1989) Growth factors as transforming proteins. Eur J Biochem 184: 487–496
Hennings H, Boutwell RK (1970) Studies on the mechanism of skin tumor promotion. Cancer Res 30: 312–320
Ho T, Horn T, Finzi E (1991) Transforming growth factor a expression helps to distinguish keratoacanthomas from squamous cell carcinomas. Arch Dermatol 127: 1167–1171
Imamoto A, Beltran LM, DiGiovanni J (1991) Evidence for autocrine/paracrine growth stimulation by transforming growth factor a during the process of skin tumor promotion. Mol Carcinog 4: 52–60
Kane CJM, Hebda PA, Mansbridge JN, Hanawalt PC (1991) Direct evidence for spatial and temporal regulation of transforming growth factor ßl expression during cutaneous wound healing. J Cell Physiol 148: 157–173
Konstantinides A, Smulow J (1982) Tumorigenesis at a predetermined oral site after one intraperitoneal injection of N-nitroso-N-methylurea. Science 216: 1235–1237
Krieg P, Schnapké R, Fürstenberger G, Vogt I, Marks F (1991) TGF-131 and skin carcinogenesis: antiproliferative effect in vitro and TGF-01 mRNA expression during epidermal hyperproliferation and multistage tumorigenesis. Mol Carcinog 4: 129–137
Kupper TS (1990) The activated keratinocyte: a model for inducible cytokine production by non-bone marrow-derived cells in cutaneous inflammatory and immune responses. J Invest Dermatol 95: 1465–150S
Larsen CG, Anderson AO, Oppenheim JJ, Matsushima K (1989) Production of interleukin 8 by human dermal fibroblasts and keratinocytes in response to interleukin 1 or tumor necrosis factor. Immunology 68: 31–36
Leder A, Kuo RD, Cardiff RD, Sinn E, Leder P (1990) v-Ha-ras transgene abrogates the initiation step in mouse skin tumorigenesis: effects of phorbol esters and retinoic acid. Proc Natl Acad Sci USA 87: 9178–9182
Lee SW, Morhenn VB, Ilnicka M, Eugui EM, Allison AC (1991) Autocrine stimulation of interleukin-la and transforming growth factor a production in human keratinocytes and its antagonism by glucocorticoids. J Invest Dermatol 97: 106–110
Lyons RM, Moses HL (1990) Transforming growth factors and the regulation of cell proliferation. Eur J Biochem 187: 467–473
Manning A, Williams AC, Game SM, Paraskeva C (1991) Differential sensitivity of human colonic adenoma and carcinoma cells to transforming growth factor ß (TGF-ß): conversion of an adenoma cell line to a tumorigenic phenotype is accompanied by a reduced to the inhibitory effects of TGF-ß. Oncogene 6: 1471–1476
Marks F (1990) Hyperplastic transformation, the response of the skin to irritation and injury. In: Galli CL, Marinovich DM, Hensby TN (eds) Skin pharmacology and toxicology. Plenum, New York, pp 121–145
Marks F, Fürstenberger G (1987) Multistage carcinogenesis-the mouse skin model. In: zurHausen H, Schlehofer JE (eds) Accomplishments in oncology, vol 2. Lippincott, Philadelphia, pp 18–30
Marks F, Fürstenberger G (1990) The conversion stage of skin carcinogenesis. Carcinogenesis 11: 2085–2092
McKay IA, Leigh IM (1991) Epidermal cytokines and their roles in cutaneous wound healing. Br J Dermatol 124: 513–518
McKenzie I, Rous P (1941) The experimental disclosure of latent neoplastic changes in tarred skin. J Exp Med 73: 391–416
McKenzie RC, Sauder DN (1990) The role of keratinocyte cytokines in inflammation and immunity. J Invest Dermatol 95: 1055–107S
Mueller CE, Thornbury JR (1973) Adenocarcinoma of the colon complicating ureterosidmoistomy: a case report and review of the literature. J Urol 109: 225–227
Mustoe TA, Pierce GF, Thamason A, Gramates P, Sporn MB, Deuel TF (1987) Accelerated healing of incisional wounds in rats induced by transforming growth factor-beta. Science 237: 1333–1336
Nickoloff GJ, Griffiths CEM, Barker JNWN (1990) The role of cell adhesion molecules, chemotactic factors, and cytokines in inflammatory and neoplastic skin diseases — 1990 update. J Invest Dermatol 97: 106–110
Nishizuka Y (1988) The molecular heterogeneity of protein kinase C and its implication for cellular regulation. Nature 334: 662–665
O’Keffe EJ, Chiu ML, Payne RE (1988) Stimulation of growth of keratinocytes by bFGF. J Invest Dermatol 90: 767–769
Parkinson EK (1985) Defective responses of transformed keratinocytes to terminal differentiation stimuli. Their role in epidermal tumor promotion by phorbol esters and by deep skin wounding Br J Cancer 52: 479–493
Parkinson EK, Balmain A (1990) Chalones revisited: a possible role of transforming growth factor-ß in tumor promotion. Carcinogenesis 11: 195–198
Pillai S, Bikle DD, Eessalu TE (1989) Binding and biological effects of tumor necrosis factor alpha on cultured human neonatal foreskin keratinocytes. J Clin Invest 83: 816–821
Pittelkow MR, Lindqusit PB, Abraham RT, Graves DR, Derynck R, Coffey RJ (1989) Induction of transforming-a expression in human keratinocytes by phorbol esters. J Biol Chem 264: 5164–5171
Pound AW, McGuirre LJ (1978) Repeated partial hepatectomy as a promoting stimulus for the carcinogenic response of liver to nitroseamines in rats. Br J Cancer 37: 585–594
Pozharizski KM (1975) The significance of nonspecific injury for colon carcinogenesis in rats. Cancer Res 35: 3824–3830
Quaglino D Jr, Nanny LB, Ditesheim JA, Davidson JM (1991) Transforming growth factor-beta stimulates wound healing and modulates extracellular matrix gene expression in pig skin: Incisional wound model. J Invest Dermatol 97: 34–42
Reusch M, Studtmann K, Schröder MJ, Sticherling M, Christophers E (1990) NAP-1/IL-8 is a potent mitogen for human keratinocytes in vitro. J Invest Dermatol 95: 485 (abstr)
Roberts AB, Sporn MB, Assoian RK, Smith JM, Roche NS, Wakefield LM, Heine U, Liotta LA, Falanger V, Kelert JH, Fanci AS (1986) Transforming growth factor type ß: rapid induction of fibrosis and angiogenesis in vivo and stimulation of collagen formation in vitro. Proc Natl Acad Sci USA 83: 4167–4171
Roberts AB, Thompson NL, Heine U, Flanders KC, Sporn MB (1988) Transforming growth factor-ß: possible roles in carcinogenesis. Br J Cancer 57: 594–600
Rubin JS, Osada H, Finch PW, Taylor WG, Rudikoff S, Aaronson SA (1989) Purification and characterization of a newly identified factor specific for epithelial cells. Proc Natl Acad Sci USA 86: 802–806
Sanderson KV, Mackie R (1979) Tumors of the skin. In: Rook A, Wilkinson DS, Ebling FJG (eds) Textbook of dermatology, vol 2. Blackwell, Oxford, pp 2186–2192
Schmidt R, Hecker E (1989) Biological assays for irritant, tumor-initiating and tumor-promoting activities: II. Standardized initation/promotion protocol and semiquantitative estimation or promoting (or iniatiating) potencies in the skin of NMRI mice. J Cancer Res Clin Oncol 115: 516–524
Schnapke R (1992) Transformierender Wadistumsfaktor ß — Expression and Effekte in Keratinocyten and während der Mehrstufen Karzinogenese in Mäusehant. Ph D thesis, University of Heidelberg
Schuh AC, Keating SJ, Monteclaro FS, Vogt PK, Breitman ML (1990) Obligatory wounding requirement for tumorigenesis in v-jun transgenic mice. Nature 346: 756–760
Schultz GS, White M, Mitchell R, Brown G, Lynch J, Twardzik DR, Todaro G (1987) Epithelial wound healing enhanced by transforming growth factor a or vaccinia growth factor. Science 235: 350–357
Shipley GD, Pittelkow MR, Wille JJ, Scott RE, Moses HL (1986) Reversible inhibition of normal human prokeratinocyte proliferation by type-ß transforming growth factor-growth inhibitor in serum free medium. Cancer Res 46: 2068–2071
Sieweke MH, Thompson NL, Sporn MB, Bissel MJ (1990) Mediation of wound- related Rous Sarcom Virus tumorigenesis by TGF-ß. Science 248: 1656–1660
Slaga TJ, Fischer SM, Nelson K, Gleason GL (1980) Studies on the mechanisms of skin tumor promotion: evidence for several stages of promotion. Proc Natl Acad Sci USA 77: 3659–3663
Sporn MB, Roberts AB (1986) Peptide growth factors and inflammation, tissue repair and cancer. J Clin Invest 78: 329–332
Vassar R, Fuchs E (1991) Transgenic mice provide new insights into the role of TGF-a during epidermal development and differentiation. Genes Dev 5: 714–727
Virchow R (1863) Die krankhaften Geschwülste. 30 Vorlesungen gehalten während des Wintersemesters 1862–1863 an der Universität Berlin. Hirschwald, Berlin
Wahl SM, Wong H, McCartney-Francis (1989) Role of growth factors in inflammation and repair. J Cell Biochem 40: 193–199
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1993 Springer-Verlag Berlin · Heidelberg
About this paper
Cite this paper
Fürstenberger, G., Krieg, P., Schnapke, R., Feil, S., Marks, F. (1993). The Role of Endogenous Factors in Skin Carcinogenesis. In: Hecker, E., Jung, E.G., Marks, F., Tilgen, W. (eds) Skin Carcinogenesis in Man and in Experimental Models. Recent Results in Cancer Research, vol 128. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-84881-0_24
Download citation
DOI: https://doi.org/10.1007/978-3-642-84881-0_24
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-642-84883-4
Online ISBN: 978-3-642-84881-0
eBook Packages: Springer Book Archive